In addition, Sema3A promoted the osteogenic differentiation of ASC sheets in vitro and local injection of Sema3A promoted T2DM rats' calvarial bone regeneration based on ASC sheets and Bio-Oss® bone granule complex treatment. The gene discussed is SEMA3A; the disease is type 2 diabetes mellitus.